Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease
2013-01-01 D'Alessio, S; Tacconi, C; Fiocchi, C; Danese, S
More on Covid-19 in Immune-Mediated Inflammatory Diseases
2020-01-01 peyrin-Biroulet, Laurent; Danese, Silvio
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2016-01-01 Danese, S; Grisham, M; Hodge, J; Telliez, Jb
The impact of biologics in surgical outcomes in ulcerative colitis
2018-01-01 Argollo, Mc; Kotze, Pg; Spinelli, A; Gomes, Tnf; Danese, S
Leukoapheresis in Crohn's disease: the final curtain?
2013-01-01 Peyrin-Biroulet, L; Danese, S
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010-01-01 Dignass, A; Van Assche, G; Lindsay, Jo; Lemann, M; Soderholm, J; Colombel, Jf; Danese, S; D'Hoore, A; Gassull, M; Gomollon, F; Hommes, Dw; Michetti, P; O'Morain, C; Oresland, T; Windsor, A; Stange, Ef; Travis, Spl
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
2019-01-01 Fiorino, G; Caprioli, F; Daperno, M; Mocciaro, F; Principi, M; Viscido, A; Fantini, Mc; Orlando, A; Papi, C; Annese, V; Danese, S; Vecchi, M; Rizzello, F; Armuzzi, A; Leone, S; Previtali, E; Aloi, M; Alvisi, P; Antonelli, E; Ardizzone, S; Astegiano, M; Baldoni, M; Beltrami, M; Biancone, L; Bodini, G; Buda, A; Bossa, F; Bracci, F; Calabrese, E; Cappello, M; Castiglione, F; Ciacci, C; Cicala, M; Ciccocioppo, R; Comberlato, M; Cortelezzi, Cc; Cosintino, R; Costa, F; Costantino, G; Cucchiara, S; Cuomo, A; D'Inca, R; Di Paolo, Mc; Di Sabatino, A; Di Sario, A; Frieri, G; Fries, W; Gasbarrini, A; Geccherle, A; Gionchetti, P; Graziani, Mg; Grossi, L; Guidi, L; Imperiali, G; Latella, G; Lionetti, P; Inserra, G; Maconi, G; Manguso, F; Marino, M; Mastronardi, M; Mazzuoli, S; Meucci, G; Mendolaro, M; Milla, M; Mocci, G; Monteleone, G; Bortoluzzi, Fn; Pagnini, C; Pastorelli, L; Pica, R; Piergallini, S; Privitera, A; Renna, S; Ribaldone, Dg; Ricci, C; Rispo, A; Rocca, R; Romano, C; Romano, M; Russo, G; Sablich, R; Saibeni, S; Savarino, E; Scribano, Ml; Spagnuolo, R; Stasi, E; Terpin, Mm; Testa, A; Valpiani, D; Variola, A; Vernia, P; Vitale, G; Zoli, G
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
2017-01-01 Colombel, Jf; Panaccione, R; Bossuyt, P; Lukas, M; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Hebuterne, X; Travis, S; Danese, S; Reinisch, W; Sandborn, Wj; Rutgeerts, P; Hommes, D; Schreiber, S; Neimark, E; Huang, Bd; Zhou, Q; Mendez, P; Petersson, J; Wallace, K; Robinson, Am; Thakkar, Rb; D'Haens, G
Are Surgical Rates Decreasing in the Biological Era In IBD?
2019-01-01 Di Candido, F; Fiorino, G; Spadaccini, M; Danese, S; Spinelli, A
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
2011-01-01 Peyrin-Biroulet, L; Ferrante, M; Magro, F; Campbell, S; Franchimont, D; Fidder, H; Strid, H; Ardizzone, S; Veereman-Wauters, G; Chevaux, Jb; Allez, M; Danese, S; Sturm, A
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA
2017-01-01 Travis, S; Feagan, Bg; Peyrin-Biroulet, L; Panaccione, R; Danese, S; Lazar, A; Robinson, Am; Petersson, J; Pappalardo, Bl; Bereswill, M; Chen, Nj; Wang, S; Skup, M; Thakkar, Rb; Chao, Jd
The CD40/CD40L costimulatory pathway in inflammatory bowel disease
2004-01-01 Danese, S; Sans, M; Fiocchi, C
Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases
2010-01-01 Danese, S; Gao, B
Is cytotoxic-associated gene A-positive Helicobacter pylori important?
2001-01-01 Danese, S; Candelli, M; Papa, A; Gasbarrini, A
The safety of vedolizumab for ulcerative colitis and Crohn's disease
2017-01-01 Colombel, Jf; Sands, Be; Rutgeerts, P; Sandborn, W; Danese, S; D'Haens, G; Panaccione, R; Loftus, Ev; Sankoh, S; Fox, I; Parikh, A; Milch, C; Abhyankar, B; Feagan, Bg
The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease
2017-01-01 Avila-Ribeiro, P; Fiorino, G; Danese, S
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease
2015-01-01 Moja, L; Danese, S; Fiorino, G; Del Giovane, C; Bonovas, S
Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review
2019-01-01 Chateau, T; Bonovas, S; Le Berre, C; Mathieu, N; Danese, S; Peyrin-Biroulet, L
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS
2019-01-01 Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; D'Haens, Gr; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
2019-01-01 Fiorino, G; Sturniolo, Gc; Bossa, F; Cassinotti, A; Di Sabatino, A; Giuffrida, P; Danese, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease | 1-gen-2013 | D'Alessio, S; Tacconi, C; Fiocchi, C; Danese, S | |
| More on Covid-19 in Immune-Mediated Inflammatory Diseases | 1-gen-2020 | peyrin-Biroulet, Laurent; Danese, Silvio | |
| JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines | 1-gen-2016 | Danese, S; Grisham, M; Hodge, J; Telliez, Jb | |
| The impact of biologics in surgical outcomes in ulcerative colitis | 1-gen-2018 | Argollo, Mc; Kotze, Pg; Spinelli, A; Gomes, Tnf; Danese, S | |
| Leukoapheresis in Crohn's disease: the final curtain? | 1-gen-2013 | Peyrin-Biroulet, L; Danese, S | |
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management | 1-gen-2010 | Dignass, A; Van Assche, G; Lindsay, Jo; Lemann, M; Soderholm, J; Colombel, Jf; Danese, S; D'Hoore, A; Gassull, M; Gomollon, F; Hommes, Dw; Michetti, P; O'Morain, C; Oresland, T; Windsor, A; Stange, Ef; Travis, Spl | |
| Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) | 1-gen-2019 | Fiorino, G; Caprioli, F; Daperno, M; Mocciaro, F; Principi, M; Viscido, A; Fantini, Mc; Orlando, A; Papi, C; Annese, V; Danese, S; Vecchi, M; Rizzello, F; Armuzzi, A; Leone, S; Previtali, E; Aloi, M; Alvisi, P; Antonelli, E; Ardizzone, S; Astegiano, M; Baldoni, M; Beltrami, M; Biancone, L; Bodini, G; Buda, A; Bossa, F; Bracci, F; Calabrese, E; Cappello, M; Castiglione, F; Ciacci, C; Cicala, M; Ciccocioppo, R; Comberlato, M; Cortelezzi, Cc; Cosintino, R; Costa, F; Costantino, G; Cucchiara, S; Cuomo, A; D'Inca, R; Di Paolo, Mc; Di Sabatino, A; Di Sario, A; Frieri, G; Fries, W; Gasbarrini, A; Geccherle, A; Gionchetti, P; Graziani, Mg; Grossi, L; Guidi, L; Imperiali, G; Latella, G; Lionetti, P; Inserra, G; Maconi, G; Manguso, F; Marino, M; Mastronardi, M; Mazzuoli, S; Meucci, G; Mendolaro, M; Milla, M; Mocci, G; Monteleone, G; Bortoluzzi, Fn; Pagnini, C; Pastorelli, L; Pica, R; Piergallini, S; Privitera, A; Renna, S; Ribaldone, Dg; Ricci, C; Rispo, A; Rocca, R; Romano, C; Romano, M; Russo, G; Sablich, R; Saibeni, S; Savarino, E; Scribano, Ml; Spagnuolo, R; Stasi, E; Terpin, Mm; Testa, A; Valpiani, D; Variola, A; Vernia, P; Vitale, G; Zoli, G | |
| Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial | 1-gen-2017 | Colombel, Jf; Panaccione, R; Bossuyt, P; Lukas, M; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Hebuterne, X; Travis, S; Danese, S; Reinisch, W; Sandborn, Wj; Rutgeerts, P; Hommes, D; Schreiber, S; Neimark, E; Huang, Bd; Zhou, Q; Mendez, P; Petersson, J; Wallace, K; Robinson, Am; Thakkar, Rb; D'Haens, G | |
| Are Surgical Rates Decreasing in the Biological Era In IBD? | 1-gen-2019 | Di Candido, F; Fiorino, G; Spadaccini, M; Danese, S; Spinelli, A | |
| Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease | 1-gen-2011 | Peyrin-Biroulet, L; Ferrante, M; Magro, F; Campbell, S; Franchimont, D; Fidder, H; Strid, H; Ardizzone, S; Veereman-Wauters, G; Chevaux, Jb; Allez, M; Danese, S; Sturm, A | |
| Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA | 1-gen-2017 | Travis, S; Feagan, Bg; Peyrin-Biroulet, L; Panaccione, R; Danese, S; Lazar, A; Robinson, Am; Petersson, J; Pappalardo, Bl; Bereswill, M; Chen, Nj; Wang, S; Skup, M; Thakkar, Rb; Chao, Jd | |
| The CD40/CD40L costimulatory pathway in inflammatory bowel disease | 1-gen-2004 | Danese, S; Sans, M; Fiocchi, C | |
| Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases | 1-gen-2010 | Danese, S; Gao, B | |
| Is cytotoxic-associated gene A-positive Helicobacter pylori important? | 1-gen-2001 | Danese, S; Candelli, M; Papa, A; Gasbarrini, A | |
| The safety of vedolizumab for ulcerative colitis and Crohn's disease | 1-gen-2017 | Colombel, Jf; Sands, Be; Rutgeerts, P; Sandborn, W; Danese, S; D'Haens, G; Panaccione, R; Loftus, Ev; Sankoh, S; Fox, I; Parikh, A; Milch, C; Abhyankar, B; Feagan, Bg | |
| The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease | 1-gen-2017 | Avila-Ribeiro, P; Fiorino, G; Danese, S | |
| Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease | 1-gen-2015 | Moja, L; Danese, S; Fiorino, G; Del Giovane, C; Bonovas, S | |
| Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review | 1-gen-2019 | Chateau, T; Bonovas, S; Le Berre, C; Mathieu, N; Danese, S; Peyrin-Biroulet, L | |
| A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS | 1-gen-2019 | Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; D'Haens, Gr; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L | |
| A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis | 1-gen-2019 | Fiorino, G; Sturniolo, Gc; Bossa, F; Cassinotti, A; Di Sabatino, A; Giuffrida, P; Danese, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1